Sener Cihan
Overview
Explore the profile of Sener Cihan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atci M, Secmeler S, Sakin A, Arici S, Can O, Selvi O, et al.
Indian J Cancer
. 2025 Feb;
61(4):714-721.
PMID: 39960699
Background: We aimed to evaluate the data of perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy regimen in locally advanced gastric cancer (LAGC) patients with real-life experience. Methods: In this...
2.
Kocak G, Bilik G, Yesilova A, Oyman F, Can M, Cihan S
Medicine (Baltimore)
. 2022 Jul;
101(26):e29814.
PMID: 35777022
Calprotectin is a protein molecule that is released from inflammatory cells. Measurement of calprotectin in various body fluids has recently gained significant importance for differentiating inflammatory and noninflammatory events. The...
3.
Akturk Esen S, Ergun Y, Erol C, Arikan R, Er M, Atci M, et al.
Bosn J Basic Med Sci
. 2022 Apr;
22(5):818-825.
PMID: 35460397
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred. This study aimed to...
4.
Celik Kamaci S, Kocak G, Yesilova A, Cihan S
Int Urol Nephrol
. 2021 Aug;
54(5):1085-1090.
PMID: 34390437
Purpose: The aim of this study was to determine the frequency and the risk factors of acute and chronic nephrotoxicity in patients who received cisplatin due to malignancy. Materials And...
5.
Sakin A, Atci M, Aldemir M, Akagunduz B, Sahin S, Arici S, et al.
Cureus
. 2021 May;
13(4):e14639.
PMID: 34046274
Objective In this study, we aimed to investigate the prognostic value of postoperative lymph node ratio (LNR)in locally advanced gastric cancer (GC) patients receiving neoadjuvant chemotherapy (NACT). Methods LNR was...
6.
Atci M, Geredeli C, Ay S, Sakin A, Erturk B, Secmeler S, et al.
Eur J Breast Health
. 2021 Apr;
17(2):123-127.
PMID: 33870111
Objective: This study aimed to determine the differences in clinicopathological features of Turkish patients with high-risk breast cancer based on the mutation status of two breast cancer susceptibility genes (BRCA1/2)...
7.
Sakin A, Sahin S, Saglampinar Karyagar S, Karyagar S, Atci M, Akboru M, et al.
J Gastrointest Cancer
. 2021 Mar;
53(2):341-347.
PMID: 33651265
Purpose: To investigate the prognostic effects of baseline volumetric PET/CT parameters including the maximum standard uptake value (SUVmax), metabolic tumor volume (MTV), and tumor lesion glycolysis (TLG) on treatment response...
8.
Sakin A, Sengul Samanci N, Secmeler S, Arici S, Can O, Yasar N, et al.
J Cancer Res Ther
. 2020 Dec;
16(Supplement):S176-S182.
PMID: 33380674
Introduction: Obesity has become one of the major public health problems in many countries. Controversial results were reported in publications on the relationship between obesity and mortality in patients diagnosed...
9.
Arici S, Sakin A, Cekin R, Secmeler S, Yasar N, Cihan S
Oncol Res Treat
. 2020 Nov;
44(1-2):12-19.
PMID: 33242864
Introduction: The length of the necessary waiting period to test driver mutations may generate anxiety in patients and clinicians. For this reason, an investigation was conducted to determine whether the...
10.
Sakin A, Sahin S, Sakin A, Atci M, Arici S, Yasar N, et al.
North Clin Istanb
. 2020 Nov;
7(5):487-493.
PMID: 33163885
Objective: This study aims to investigate the factors affecting survival in operated pancreatic ductal adenocarcinoma (PDAC) and the possible prognostic effect of primary tumor localization on treatment outcomes. Methods: In...